Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage III”

586 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 586 results

Testing effectiveness (Phase 2)Study completedNCT03200847
What this trial is testing

Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaAdvanced Melanoma
University of Colorado, Denver 26
Early research (Phase 1)Ended earlyNCT00492440
What this trial is testing

Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Cytheris SA 9
Testing effectiveness (Phase 2)Study completedNCT00350597
What this trial is testing

GM-CSF as Adjuvant Therapy of Melanoma

Who this might be right for
Malignant Melanoma
Northern California Melanoma Center 50
Not applicableStudy completedNCT02129049
What this trial is testing

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

Who this might be right for
Breast CancerCervical CancerColon Cancer+5 more
University of Washington 35
Testing effectiveness (Phase 2)Study completedNCT02259231
What this trial is testing

RTA 408 Capsules in Patients With Melanoma - REVEAL

Who this might be right for
MelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma
Biogen 41
Testing effectiveness (Phase 2)Study completedNCT04526899
What this trial is testing

Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVUnresectable Melanoma
BioNTech SE 184
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Testing effectiveness (Phase 2)WithdrawnNCT04995094
What this trial is testing

Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma

Who this might be right for
Pathologic Stage III Cutaneous Melanoma AJCC v8
HiberCell, Inc.
Not applicableLooking for participantsNCT02828202
What this trial is testing

Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Who this might be right for
Malignant Melanoma
Assistance Publique - Hôpitaux de Paris 6,000
Testing effectiveness (Phase 2)Study completedNCT00243529
What this trial is testing

Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 64
Large-scale testing (Phase 3)Study completedNCT00111007
What this trial is testing

A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Bayer 270
Early research (Phase 1)Study completedNCT02318771
What this trial is testing

Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Renal Cell CancerRecurrent Head and Neck Carcinoma+6 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 41
Testing effectiveness (Phase 2)Study completedNCT00338130
What this trial is testing

Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Who this might be right for
Melanoma
AstraZeneca 239
Not applicableLooking for participantsNCT05527795
What this trial is testing

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma

Who this might be right for
Melanoma
Hospices Civils de Lyon 1,000
Large-scale testing (Phase 3)Looking for participantsNCT06794775
What this trial is testing

SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma

Who this might be right for
Malignant Melanoma Stage III
Hildur Helgadottir 128
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Testing effectiveness (Phase 2)Looking for participantsNCT05428007
What this trial is testing

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
MelanomaUnresectable Melanoma
NYU Langone Health 105
Early research (Phase 1)Active Not RecruitingNCT03816332
What this trial is testing

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04207086
What this trial is testing

A Phase II Study of Neoadjuvant Pembrolizumab & Lenvatinib for Resectable Stage III Melanoma

Who this might be right for
Melanoma Stage III
Melanoma Institute Australia 21
Large-scale testing (Phase 3)Ended earlyNCT01264874
What this trial is testing

MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients

Who this might be right for
Melanoma
European Institute of Oncology 150
Load More Results